Phase IIB TL + YCWP + DC in Melanoma
Clinical trial NCT02301611 · COMPLETED
Trial details
- NCT number
- NCT02301611
- Sponsor
- Elios Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2022-05-11
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.